Valuation Stryker Corporation Toronto S.E.
Stocks
SYK
CA8636701051
Medical Equipment, Supplies & Distribution
|
Delayed
Toronto S.E.
20:47:00 19/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 20.14 CAD | +1.41% |
|
+5.67% | - |
| 10-14 | Stryker Launches Sonopet 3, Delivering Greater Power And Precision In Ultrasonic Tissue Removal | CI |
| 10-14 | Stryker Receives FDA Clearance for Ultrasonic Tissue Removal Platform | MT |
Company Valuation: Stryker Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 100,882 | 92,522 | 113,776 | 137,257 | 134,410 | 113,024 | - | - |
| Change | - | -8.29% | 22.97% | 20.64% | -2.07% | -15.91% | - | - |
| Enterprise Value (EV) 1 | 110,335 | 102,451 | 121,655 | 144,952 | 146,258 | 122,274 | 118,850 | 115,491 |
| Change | - | -7.14% | 18.74% | 19.15% | 0.9% | -16.4% | -2.8% | -2.83% |
| P/E | 51.3x | 39.6x | 36.3x | 46.4x | 41.8x | 23x | 20.1x | 17.8x |
| PBR | 6.79x | 5.56x | 6.11x | 6.65x | 5.99x | 4.3x | 3.71x | 3.2x |
| PEG | - | 2.1x | 1.1x | -7.81x | 5.07x | 0.4x | 1.4x | 1.4x |
| Capitalization / Revenue | 5.9x | 5.02x | 5.55x | 6.07x | 5.35x | 4.16x | 3.83x | 3.56x |
| EV / Revenue | 6.45x | 5.55x | 5.93x | 6.42x | 5.82x | 4.5x | 4.03x | 3.63x |
| EV / EBITDA | 23.2x | 21.5x | 22.7x | 23.6x | 20.7x | 15.7x | 13.9x | 12.2x |
| EV / EBIT | 25.2x | 23.4x | 24.6x | 25.4x | 22.2x | 16.8x | 14.8x | 13.1x |
| EV / FCF | 40.3x | 50.3x | 39.2x | 41.6x | 34.1x | 30.5x | 24x | 20.4x |
| FCF Yield | 2.48% | 1.99% | 2.55% | 2.41% | 2.93% | 3.28% | 4.18% | 4.91% |
| Dividend per Share 2 | 2.585 | 2.835 | 3.05 | 3.24 | 3.4 | 3.594 | 3.824 | 4.107 |
| Rate of return | 0.97% | 1.16% | 1.02% | 0.9% | 0.97% | 1.22% | 1.3% | 1.39% |
| EPS 2 | 5.21 | 6.17 | 8.25 | 7.76 | 8.4 | 12.82 | 14.66 | 16.52 |
| Distribution rate | 49.6% | 45.9% | 37% | 41.8% | 40.5% | 28% | 26.1% | 24.9% |
| Net sales 1 | 17,108 | 18,449 | 20,498 | 22,595 | 25,116 | 27,170 | 29,490 | 31,778 |
| EBITDA 1 | 4,753 | 4,755 | 5,348 | 6,142 | 7,064 | 7,792 | 8,559 | 9,429 |
| EBIT 1 | 4,382 | 4,384 | 4,955 | 5,715 | 6,603 | 7,260 | 8,023 | 8,848 |
| Net income 1 | 1,994 | 2,358 | 3,165 | 2,993 | 3,246 | 4,928 | 5,721 | 6,373 |
| Net Debt 1 | 9,453 | 9,929 | 7,879 | 7,695 | 11,848 | 9,250 | 5,827 | 2,467 |
| Reference price 2 | 267.42 | 244.49 | 299.46 | 360.05 | 351.47 | 294.66 | 294.66 | 294.66 |
| Nbr of stocks (in thousands) | 377,240 | 378,430 | 379,938 | 381,216 | 382,424 | 383,573 | - | - |
| Announcement Date | 27/01/22 | 31/01/23 | 30/01/24 | 28/01/25 | 29/01/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.95x | 4.09x | 15.82x | 2.45% | 181B | |
| 20.26x | 3.52x | 12.59x | 2.99% | 116B | |
| 22.98x | 4.5x | 15.69x | 1.22% | 113B | |
| 27.35x | 2.68x | 10.75x | 2.64% | 79.83B | |
| 18.7x | 0.22x | 13.49x | 0.7% | 65.06B | |
| 31.17x | 7.75x | 19.98x | 1.28% | 54.35B | |
| 36.95x | 3.53x | 12.1x | 2.05% | 52.23B | |
| 37.95x | 9.42x | 26.36x | -.--% | 44.15B | |
| 34.57x | 6.06x | 19.03x | -.--% | 32.47B | |
| Average | 28.99x | 4.64x | 16.20x | 1.48% | 82.07B | |
| Weighted average by Cap. | 27.60x | 4.20x | 15.35x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SYK Stock
- SYK Stock
- Valuation Stryker Corporation
Select your edition
All financial news and data tailored to specific country editions
